Friday, 3 September 2010

Daily Mail misses the point...again

The shock news of the week, apparently, is the fact that NICE has spent LOADS of money on themselves instead of spending it on cancer drugs (the b*stards).

Except, erm, as I've posted before, NICE doesn't pay for these drugs - it merely recommends medical treatments based on a cost-benefit analysis (boring I know, and clearly not as efficient as the Daily Mail approach, which is based on ignorant conjecture).

True to form, the Mail have also wheeled-out (not for the first time) a balanced critic of NICE to further their argument.

No comments:

Post a Comment